Travere Therapeutics, Inc. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Travere Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Travere Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -542 %, a 877% decline year-over-year.
  • Travere Therapeutics, Inc. annual Return On Equity for 2023 was -56.7 %, a 74.1% increase from 2022.
  • Travere Therapeutics, Inc. annual Return On Equity for 2022 was -219 %, a 297% decline from 2021.
  • Travere Therapeutics, Inc. annual Return On Equity for 2021 was -55.2 %, a 13.9% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -56.7 +162 +74.1% Jan 1, 2023 Dec 31, 2023
2022 -219 -164 -297% Jan 1, 2022 Dec 31, 2022
2021 -55.2 +8.89 +13.9% Jan 1, 2021 Dec 31, 2021
2020 -64.1 -7.25 -12.7% Jan 1, 2020 Dec 31, 2020
2019 -56.9 -23.3 -69.6% Jan 1, 2019 Dec 31, 2019
2018 -33.5 -13.5 -67.6% Jan 1, 2018 Dec 31, 2018
2017 -20 -4.66 -30.4% Jan 1, 2017 Dec 31, 2017
2016 -15.3 -66.9 -130% Jan 1, 2016 Dec 31, 2016
2015 51.5 -491 -90.5% Jan 1, 2015 Dec 31, 2015
2014 543 +207 +61.8% Jan 1, 2014 Dec 31, 2014
2013 335 -3.04K -90.1% Jan 1, 2013 Dec 31, 2013
2012 3.37K Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.